KEY:NYSEKeyCorp Analysis
Data as of 2026-03-10 - not real-time
$19.76
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
KeyCorp (KEY) is trading at $19.76, which sits below its 20‑day (21.22) and 50‑day (21.39) simple moving averages, indicating short‑term weakness, while the 200‑day SMA (18.92) provides a modest long‑term support level. The RSI of 35 points toward an oversold condition and the bearish MACD histogram reinforces downward momentum, though volume has been decreasing, suggesting limited immediate buying pressure.
Fundamentally, the stock appears markedly cheap: a trailing P/E of 13 versus the industry average of 17.3, a price‑to‑book of 1.22, and a dividend yield of 4.16% with a 54% payout ratio, indicating sustainable income. The DCF‑derived fair value of $45.36 implies upside of over 20% and the consensus “Buy” rating (median target $24) together with Baird’s recent upgrade to Neutral reinforce the valuation case. While beta (1.17) and 30‑day volatility (32%) signal higher market sensitivity, the company’s disciplined capital‑return strategy and solid cash generation mitigate risk, positioning KEY for a potential rebound in the near term and continued upside over medium to long horizons.
Fundamentally, the stock appears markedly cheap: a trailing P/E of 13 versus the industry average of 17.3, a price‑to‑book of 1.22, and a dividend yield of 4.16% with a 54% payout ratio, indicating sustainable income. The DCF‑derived fair value of $45.36 implies upside of over 20% and the consensus “Buy” rating (median target $24) together with Baird’s recent upgrade to Neutral reinforce the valuation case. While beta (1.17) and 30‑day volatility (32%) signal higher market sensitivity, the company’s disciplined capital‑return strategy and solid cash generation mitigate risk, positioning KEY for a potential rebound in the near term and continued upside over medium to long horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Technical oversold signals (RSI 35) and price below short‑term SMAs
- High dividend yield with sustainable payout
- Recent analyst upgrade improving valuation perception
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap to DCF fair value
- Consistent dividend and capital return policy
- Positive consensus price targets and buy rating
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Undervalued relative to peers and industry multiples
- Sustainable cash flow supporting dividend and growth
- Strategic positioning in regional banking with potential consolidation benefits
Key Metrics & Analysis
Financial Health
Revenue Growth131.50%
Profit Margin26.10%
P/E Ratio13.0
ROE9.48%
ROA0.98%
P/B Ratio1.2
Op. Cash Flow$2.2B
Industry P/E17.3
Technical Analysis
TrendNeutral
RSI35.1
Support$18.97
Resistance$23.30
MA 20$21.22
MA 50$21.39
MA 200$18.92
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair Value$45.36
Target Price$24.55
Upside/Downside24.23%
GradeUndervalued
TypeBlend
Dividend Yield4.16%
Risk Assessment
Beta1.17
Volatility32.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.